SCHEMBL4938201

SCHEMBL4938201

B.c1ccc(Cc2ccccn2)nc1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.57
HRH1 P35367 2/20 0.56
HRH3 Q9Y5N1 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.54
MAPT P10636 1/20 0.54
LIN28A Q9H9Z2 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
LMNA P02545 1/20 0.54
TAAR1 Q96RJ0 1/20 0.54
ALDH1A1 P00352 1/20 0.54
ALOX15 P16050 1/20 0.54
HRH4 Q9H3N8 1/20 0.53
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
ASIC3 Q9UHC3 1/20 0.50
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29830938 0.97 L3MBTL1 (0.59) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
SCHEMBL41191 0.97 L3MBTL1 (0.59) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL10884973 0.94 L3MBTL1 (0.57) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
SCHEMBL4938207 0.94 L3MBTL1 (0.57) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
Ammonia Solution, Strong SCHEMBL6176560 0.94 L3MBTL1 (0.57) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
Bromide SCHEMBL6114859 0.94 L3MBTL1 (0.57) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
SCHEMBL29715188 0.94 L3MBTL1 (0.57) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
SCHEMBL7948123 0.87 HRH3 (0.55) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
SCHEMBL7948124 0.87 HRH3 (0.55) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
Dipyridyl SCHEMBL4975687 0.87 KDM4E (0.67) L3MBTL1HRH1HRH3SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7329466-B2 Organic element for electroluminescent devices EASTMAN KODAK COMPANY (US) 2008-02-12 US disclosed
US-20060210829-A9 Organic element for electroluminescent devices EASTMAN KODAK COMPANY 2006-09-21 US disclosed
WO-2005076385-A1 A BIS(AZINYL) METHENE BORON COMPLEX USED AS AN EMISSIVE DOPANT IN AN ORGANIC LIGHT EMITTING DEVICE EASTMAN KODAK COMPANY (US) 2005-08-18 WO disclosed
US-20050170204-A1 Organic element for electroluminescent devices EASTMAN KODAK COMPANY 2005-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060210829-A9 Organic element for electroluminescent devices EED, JUND, OCIAD2 L3MBTL1 494/4885HRH1 3094/4885HRH3 2085/4885
US-20050170204-A1 Organic element for electroluminescent devices EED, JUND, OCIAD2 L3MBTL1 494/4885HRH1 3094/4885HRH3 2085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.